OpenVSafe by OpenVAERS
Search V-safe

WRA-36168-32936

1 vaccination 2 coded responses 8 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
549 / WI
Registered
2021-01-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-21
    Registered in v-safe
  2. 2021-01-21
    Dose 1 — Moderna
  3. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches
    Adult check-in
  4. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  5. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-28
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-04
    Survey response — day 14, dose 1
    MedDRA: Nasal congestion, Nasopharyngitis, Rhinorrhoea — Feeling: Poor
    Free text: Cold symptoms, mostly nasal congestion and runny nose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-11
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-04-22
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  10. 2022-01-23
    Survey response — 12 months, dose 1
    MedDRA: Asthma — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Asthma
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-01-23
    Report sent to call center — 12 months, dose 1
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  12. 2022-01-25

Vaccinations

DoseDateManufacturerCo-administered
12021-01-21Moderna

Call center

ReportedOutcomeVAERS-related outcome
2022-01-23 Unsuccessful

Free text

Release 3 — day 14, dose 1

2021-02-04

Symptoms: Cold symptoms, mostly nasal congestion and runny nose.

Release 11 — 12 months, dose 1

2022-01-23

Symptoms: Asthma

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthma · · ✓
SDNasal congestion ✓ ✓ ✓
SDNasopharyngitis ✓ ✓ ✓
SDRhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release